Preladenant Terminated Phase 3 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01155479A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)